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Abstract
The wing Somatic Mutation and Recombination Test (SMART) in D. melanogaster was used to study genotoxicity of
the medicinal plant Tabebuia impetiginosa. Lapachol (naphthoquinone) and -lapachone (quinone) are the two main
chemical constituents of T. impetiginosa. These compounds have several biological properties. They induce
apoptosis by generating oxygen-reactive species, thereby inhibiting topoisomerases (I and II) or inducing other en-
zymes dependent on NAD(P)H:quinone oxidoreductase 1, thus affecting cell cycle checkpoints. The SMART was
used in the standard (ST) version, which has normal levels of cytochrome P450 (CYP) enzymes, to check the direct
action of this compound, and in the high bioactivation (HB) version, which has a high constitutive level of CYP en-
zymes, to check for indirect action in three different T. impetiginosa concentrations (10%, 20% or 40% w/w). It was
observed that T. impetiginosa alone did not modify the spontaneous frequencies of mutant spots in either cross. The
negative results observed prompted us to study this phytotherapeuticum in association with the reference mutagen
doxorubicin (DXR). In co-treated series, T. impetiginosa was toxic in both crosses at higher concentration, whereas
in the HB cross, it induced a considerable potentiating effect (from ~24.0 to ~95.0%) on DXR genotoxity. Therefore,
further research is needed to determine the possible risks associated with the exposure of living organisms to this
complex mixture.
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Introduction
Tabebuia impetiginosa (Lamiales, Bignoniaceae),
popularly known as Ipê, pau d’arco, pink trumpet tree,
taheebo and lapacho rosado, is a medicinal plant, native to
tropical rain forests and the ‘cerrado’ (savannah) through-
out Central and South America. Tabebuia spp is used in the
construction of external structures, stairs and parquets
(Algranti et al., 2005). Tabebuia impetiginosa (Martius ex
DC) Standley has been used in folk medicine as a diuretic
and astringent, as well as for treating ulcers, syphilis, gas-
trointestinal problems, candidiasis, cancer, diabetes, pros-
tatitis, constipation and allergies (Almeida, 1993; Park et
al., 2003).
The bark of the Tabebuia spp stem is a source of
furanonaphthoquinones, quinines, naphthoquinones, ben-
zoic acid, benzaldehyde derivatives, cyclopentene
dialdehyde and flavonoids (Zani et al., 1991; Koyama et
al., 2000; Park et al., 2003). Further constituents from the
bark of T. impetiginosa are iridoid glycosides, lignan gly-
cosides, isocoumarin glycosides, phenylethanoid glyco-
sides and phenolic glycosides (Warashina et al., 2004;
2005; 2006). Lapachol [2-hydroxy-3-(3-methyl-2-bute-
nyl)-1,4-naphtalene-dione],naphthoquinoneanditsderiva-
tive -Lapachone (2,2-dimethyl-3,4-dihydro-2,4-ben-
zo[h]chromene-5,6-dione), which possess biologically
active properties, can be isolated from T. impetiginosa
(Park et al., 2003). The inner bark extract of this plant po-
tently inhibited cell proliferation and DNA synthesis (Son
et al., 2006). The stereo-selective synthesis of biologically
active naphthoquinones from Tabebuia avellanedae,a sd e -
scribed by Yamashita et al. (2007), displayed potent cyto-
toxicity against several human tumor cell lines, whereas it
showed lower cytotoxicity against certain normal human
cell lines when compared with that of mitomycin. A syn-
thetic version of the natural product -lapachone has been
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Research Articleisolated from T. impetiginosa, and has also demonstrated
promising anticancer activity (Savage et al., 2008).
The T. impetiginosa bark compounds lapachol and
-lapachone are reportedly antipsoriatic, antifungal, anti-
microbial, antioxidant, antiviral, anti-inflammatory, antiul-
cerogenic, anticarcinogenic, antibacterial and antimalarial,
besides possessing antitrypanosomal activity and acting as
a chemoprophylactic against infection by Schistosoma
mansoni cercariae (Anesini and Perez, 1993; Müller et al.,
1999; Fonseca et al., 2003; Park et al., 2003, 2005, 2006;
Menna-Barreto et al., 2005). An overview of Lapachol is
presented by Hussain et al. (2007).
The anthracycline antibiotic doxorubicin is a topoi-
somerase II inhibitor (Swift et al., 2008) and a generator of
oxygen free radicals (Doroshow, 1983). Previous studies
have shown that DXR induces preferentially homologous
recombinationcomparedwithmutationaleventsinsomatic
cells of D. melanogaster (Lehmann et al., 2003; Fragiorge
et al., 2007; Pereira et al., 2008; Silva et al., 2008; Vala-
dares et al., 2008).
The wing spot test in Drosophila melanogaster (So-
matic Mutation and Recombination Test - SMART) is a
versatile, efficient and inexpensive short-term in vivo
genotoxicity assay for the detection of genotoxicity in-
duced by single pure compounds and complex mixtures.
Forthisreason,itisalsoideallysuitedforanti-genotoxicity
studies as well as for investigations into the modulation of
genotoxicity (Graf et al., 1998). It was developed to detect
the loss of heterozygosity of the marker genes expressed
phenotypically in the trichomes of the fly’s wings. It pro-
videsrapidinformationontheabilityofgenotoxicagentsto
induce (or of antigenotoxic agents to inhibit) point muta-
tions, chromosome breaks or losses during cell division, or
therearrangementrelatedtomitoticrecombination(Grafet
al., 1984; 1989; Guzmán-Rincón and Graf, 1995; Vogel et
al., 1999). Previous studies have shown that SMARTs are
best suited for the detection of recombinogenic activity of
genotoxicchemicals(Spanóetal.,2001).Thestandardver-
sion presents basal levels of cytochrome P450 (CYP) en-
zymes (Graf et al., 1989), whereas the high bioactivation
version presents a high level of CYP (Graf and van Schaik,
1992) with the capacity to activate promutagens and
procarcinogens enzymatically (Frölich and Würgler, 1990;
Graf and Singer, 1992; Graf and van Schaik, 1992).
For antigenotoxicity and modulatory studies, the
SMART assays offer a wide variety of flexible protocols
for the application of test compounds (Graf et al., 1998).
Owing to these advantages, SMART has been adopted for
the genotoxicity / antigenotoxicity / modulatory testing of
natural products (Sousa et al., 2003; Fragiorge et al., 2007;
Pereira et al., 2008; Valadares et al., 2008).
Due to the wide distribution of the genus Tabebuia,
consisting of about 20 species of trees, its use in folk medi-
cine and the lack of information related to genetic toxicol-
ogy, it is important to evaluate: i) the genotoxicity of its
leaves, stem bark, pods, and seed extracts, as these may be
potentially mutagenic, clastogenic, recombinogenic,
and/or carcinogenic in man; ii) its modulatory effects,
which enable its use as a chemotherapeutic coadjuvant.
The aim of this study was to evaluate the genotoxic
potential of a commercially available product of T.
impetiginosa bark and stem, since this is a natural product
widelyusedinfolkmedicineinBrazil.Thenegativeresults
observed with T. impetiginosa in the somatic cells of D.
melanogaster prompted us to study this phytotherapeu-
ticum in association with the reference mutagen DXR.
Material and Methods
Chemical compounds and media
A commercial preparation of the powdered bark and
trunk of T. impetiginosa - Ipê Roxo Max
® - was obtained
from Saúde na Rede (Rio de Janeiro, RJ, Brazil). Doxo-
rubicin (DXR) - Korea United Pharm Inc Co., Ltd. (Seoul,
Korea) - was obtained from Meizler Comércio Interna-
cional S.A. (Barueri, SP) and dissolved in ultrapure water
in the absence of light. Ultrapure water, used as a negative
control, was obtained from a MilliQ system (Millipore,
Vimodrone, Milan, Italy). All solutions were always
freshlypreparedinultrapurewaterimmediatelybeforeuse.
Drosophila strains
Three strains were used for crossbreeding: (i) multi-
ple wing hairs (mwh): mwh/mwh; (ii) flare-3 (flr
3/In
(3LR)TM3, rip
p sep l(3)89Aabx
34e eB d
S); and (iii) ORR;
flare-3 (ORR/ORR; flr
3/In (3LR)TM3, rip
p sep
l(3)89Aabx
34e eB d
S). More details on the genetic markers
are given by Lindsley and Zimm (1992).
Crossbreedings for the SMART assays
Two crosses were carried out: (1) the Standard (ST)
cross, where flare-3 females were mated with mwh males
(Graf et al., 1989); and (2) the High Bioactivation (HB)
cross, where ORR; flare-3 females were mated with mwh
males (Graf and van Schaik, 1992). The latter cross is
highly sensitive to promutagens and procarcinogens due to
the increased level of CYP. The ORR; flare-3 strain has
chromosomes1and2substitutedinthewildDDT-resistant
Oregon R (R) strain, and the gene (R) of chromosome 2 is
responsible for the high constitutive level of CYP enzymes
(Dapkus and Merrell, 1977; Frölich and Würgler, 1989).
Two types of individuals emerge from both ST and
HB crossbreeding: marker trans-heterozygous (MH) flies
(mwh +/+ flr
3) and balancer-heterozygous (BH) flies (mwh
+/+TM3, Bd
S). The latter can be distinguished phenotypi-
cally by its serrated wings.
Experimental procedure
After two days of crossbreeding, the couples were
transferred to the oviposition medium (an agar-agar base
Sousa et al. 383(3% w/v) and a layer of fermenting live baker’s yeast sup-
plemented with sucrose) where they remained for 8 h, after
which they were discarded. Third instar larvae (72 h  4h )
were transferred to glass vials containing different quanti-
ties (10%, 20% or 40% w/w) of powdered bark and stem of
T. impetiginosa mixed with mashed potato flakes (Yoki
Alimentos S. A. - São Bernardo do Campo, SP, Brazil),
lightly ground by using a mortar and pestle, and rehydrated
with 5 mL of ultrapure water (to evaluate the genotoxic ef-
fects of T. impetiginosa) or DXR (0.125 mg mL
-1) (to eval-
uate the modulatory effects of T. impetiginosa). Negative
(ultrapure water) and positive (DXR 0.125 mg mL
-1) con-
trols were included in both experiments.
Thelarvaewerekeptintheculturemediaatatemper-
ature of 25 °C and relative humidity of 65% until the adult
stage. Emerged adult flies were stored in 70% ethanol. The
wings were mounted on glass slides and analyzed by opti-
cal microscopy with 400 x magnification, revealing single
spots (mwh or flr) or twin spots (mwh and flr). For further
details of this procedure, see Graf et al. (1984).
Evaluation of the data and statistical analysis
The frequency of spots per fly in each series was com-
paredwiththenegativecontroltoevaluategenotoxiceffects.
In order to assess antigenotoxic effects, the frequency of
spots per fly in each treated series was compared with the
positive control. Statistical comparisons were made using
the SMART computer program, which uses the chi-square
test for proportions and allows for a multi-decision proce-
dure (Frei and Würgler, 1988). For final statistical analysis
of all positive outcomes, the non-parametric Mann-Whitney
U-testwithsignificancelevels==0.05wasusedinorder
toexcludefalsepositives(FreiandWürgler,1995).Basedon
clone induction frequencies per 10
5 cells, recombinogenic
activity was calculated as: mutation frequencies (FM) = fre-
quencies clones BH flies/frequencies clones MH flies; re-
combination frequencies (FR)=1 -FM. Frequencies of total
spots(FT)=totalspotsinMHflies(consideringmwhandflr
3
spots)/No.offlies;mutation=FTxFM;recombination=FTx
FR (Santos et al., 1999; Sinigaglia et al., 2006). Based on
control-corrected spot frequencies per 10
5 cells, the percent-
ages of T. impetiginosa inhibition were calculated as: (DXR
alone-T.impetiginosaplusDXR/DXRalone)x100(Abra-
ham, 1994).
Results
Priortogenotoxicityassessment,thecommercialprep-
aration of the powdered bark and stem of T. impetiginosa
was submitted to a dose-range test (data not shown), which
demonstrated that T. impetiginosa presented toxicity in lar-
vae fed for 48 h. The non-toxic (10 and 20%) and less-toxic
(40%) concentrations from all those tested were used to per-
form mutagenic/recombinogenic evaluation. T.
impetiginosa (10%, 20% or 40% w/w) alone, the reference
mutagen (DXR 0.125 mg mL
-1) alone and T. impetiginosa
(10%, 20% or 40% w/w) in association (co-treatment) with
DXR 0.125 mg mL
-1 were assayed twice in ST and HB
crossbreeds. Concurrent negative and positive controls were
also included. Since no statistical differences were found
among the results of individual experiments, data were
pooled. Tables 1 and 2 present the results observed with MH
andBHfliesof,respectively,theSTandHBcrossbreeds.To
assess the statistical significance of the frequency of mutant
spots observed among flies treated with T. impetiginosa, the
results were compared with data from the corresponding
negative controls. No significant differences in the fre-
quency of mutant spots were observed among flies treated
with all the T. impetiginosa concentrations and the negative
control in ST and HB crossbreeds MH flies.
To evaluate the statistical significance of co-treat-
mentseries,theresultsofthedifferentT.impetiginosacon-
centrations in association with DXR were compared with
the positive control.
IntheMHfliesoftheSTcrossbreed,thefrequencyof
mutant spots observed between those co-treated with T.
impetiginosa 10% or 20% and DXR showed no statistical
significance, but T. impetiginosa 40% in association with
DXR presented a weak positive diagnosis, displaying a
36.63% inhibition of DXR genotoxicity. The wings of BH
flies were mounted and analyzed whenever a positive re-
sponsewasobtainedintheMHoffspring.Inthiscase,asno
significant differences in the frequency of mutant spots
were observed among flies co-treated with T. impetiginosa
10% or 20% and DXR compared to flies treated with DXR
alone, the BH flies from these treated series were not ana-
lyzed. When the BH flies co-treated with T. impetiginosa
40% w/w and DXR were checked, an inhibitory effect
againstthefrequencyoftotalspots(26.08%)wasobserved.
Comparisons between the clone induction frequencies per
10
5 cells observed in the MH and BH flies of the co-treated
series with DXR and T. impetiginosa 40%, were done to
quantify the mutagenic and recombinogenic potential of T.
impetiginosa. The results showed that the genotoxicity in
MH flies was mainly due to mitotic recombination (~90%)
(Table 1).
In MH flies of the HB crossbreed, the frequency of
mutant spots observed among those co-treated with T.
impetiginosa 10%, 20% or 40% and DXR showed a posi-
tiveincrease(respectively,94.61;76.25and23.75%)inthe
total number of spots, when compared with DXR alone.
WhentheBHfliestreatedwithT.impetiginosa10%w/win
association with DXR were checked, a positive increase
(119.33%) in the total number of spots was noted. When
comparisons between the clone induction frequencies per
10
5 cells observed in the MH and BH flies of the co-treated
series with DXR and all concentrations of T. impetiginosa,
were done, the results showed that the enhancement of
genotoxicity in MH flies was mainly due to mitotic recom-
bination (87%-90%) (Table 2).
384 Modulatory effects of Tabebuia impetiginosaDiscussion
Our study shows that a commercial preparation of
powdered bark and stem of T. impetiginosa was toxic but
did not induce somatic mutation and recombination in D.
melanogaster from ST and HB crossbreeding. This means
that T. impetiginosa alone neither acts as a genotoxin nor
exerts any antigenotoxic effects on spontaneous DNA le-
sions. Nevertheless, this toxicity is revealed by the
diminished number of treated survivors.
DXR produced statistically significant induction of
all categories of spots in both the ST and HB crossbreeds.
These results are in line with those reported by Lehmann et
al. (2003), Fragiorge et al. (2007), Pereira et al. (2008) and
Valadaresetal.(2008),whoalsodemonstratedthatDXRis
a preferential inducer of homologous recombination, when
Sousa et al. 385
Table 2 - Summary of results obtained with the Drosophila wing spot test (SMART) in the marker-trans-heterozygous (MH) and balancer-heterozygous
(BH) progeny of the high bioactivation (HB) cross after chronic treatment of larvae with Tabebuia impetiginosa (Ti) and doxorubicin (DXR).
Genotypes and
treatment
Number
of flies
Spot for fly (number of spots)
statistical diagnosis
a
Spots with
mwh
clone
b (n)
Frequency of clone
formation/10
5 cells
c
Recombi-
nation (%)
Induction
d
(%)
DXR
(mg mL
-1)
Ti (%) Small single
spots (1-2 cells)
e
Large single
spots (> 2 cells)
e
Twin spots Total spots Observed Control
corrected
MH
3
0 0 40 0.85 (34) 0.00 (00) 0.01 (04) 0.95 (38) 38 1.95
0 10 38 0.97 (37) 0.08 (03) 0.13 (05) 1.18 (45) 45 2.43 0.48
0 20 40 0.85 (34) 0.08 (03) 0.00 (00) 0.93 (37) 37 1.90 -0.05
0 40 32 0.63 (20) 0.03 (01) 0.06 (02) 0.72 (23) 23 1.47 -0.47
0.125 0 40 2.10 (84)+ 1.55 (62)+ 2.58(103)+ 6.23 (249)+ 241 12.35 10.40 87.50
0.125 10 40 3.35 (134)* 3.20 (128)* 4.65 (186)* 11.20 (448)* 433 22.17 20.24 87.00 94.61
0.125 20 38 3.45 (131)* 3.26 (124)* 3.84 (146)* 10.55(401)* 376 20.28 18.33 90.30 76.25
0.125 40 35 2.71 (95) 1.77 (62) 3.06 (107) 7.54 (264)* 256 14.99 12.87 90.00 23.75
BH
3
0 0 40 0.20 (08) 0.00 (00)
f 0.20 (08) 8 0.41
0.125 0 41 0.68 (28)+ 0.10 (04) 0.78 (32)+ 32 1.60 1.19
0.125 10 40 1.20 (48)* 0.28 (11) 1.48 (59)* 59 3.02 2.61 119.33
0.125 20 40 1.00 (40) 0.03 (01) 1.03 (41) 41 2.10 1.69
0.125 40 31 0.74 (23) 0.03 (01) 0.77 (24) 24 1.59 1.06
MH flies (mwh/flr
3) and BH flies (mwh/TM3) were evaluated.
aStatistical diagnoses according to Frei and Würgler (1995). U-test, two-sided, probability
levels: +, p  0.05 vs. untreated control; *, p  0.05 vs. DXR only.
bConsidering mwh clones from mwh single and twin spots.
cFrequency of clone forma-
tion: clones/flies/48,800 cells (without size correction).
dCalculated as [DXR alone - (DXR + Ti) / DXR alone] X 100, according to Abraham (1994).
eIn-
cluding rare flr
3 single spots.
fOnly mwh single spot can be observed in BH individuals.
Table 1 - Summary of results obtained with the Drosophila Wing spot test (SMART) in the marker trans-heterozygous (MH) and balancer-heterozygous
(BH) progeny of the standard (ST) cross after chronic treatment of larvae with Tabebuia impetiginosa (Ti) and doxorubicin (DXR).
Genotypes and
treatment
Number
of flies
Spot for fly (number of spots)
statistical diagnosis
a
Spots with
mwh
clone
b (n)
Frequency of clone
formation/10
5 cells
c
Recombi-
nation (%)
inhibition
d
(%)
DXR
(mg mL
-1)
Ti (%) Small single
spots (1-2 cells)
e
Large single
spots (> 2 cells)
e
Twin spots Total spots Observed Control
corrected
MH
3
0 0 55 0.44 (24) 0.04 (02) 0.04 (02) 0.51 (28) 27 1.01
0 10 40 0.51 (28) 0.13 (07) 0.00 (00) 0.64 (35) 34 1.27 0.26
0 20 55 0.38 (21) 0.07 (04) 0.02 (01) 0.47 (26) 26 0.97 -0.04
0 40 54 0.57 (31) 0.04 (02) 0.02 (01) 0.63 (34) 34 1.29 0.28
0.125 0 40 2.40 (96)+ 2.33 (93)+ 2.60 (104)+ 7.33 (293)+ 276 14.14 13.22 88.70
0.125 10 40 2.08 (83) 2.13 (85) 3.78 (151)* 7.98(319) 306 15.68 14.75
0.125 20 40 2.13 (85) 2.20 (88) 3.10(124) 7.43(297) 288 14.75 13.83
0.125 40 38 1.71 (65)* 1.39 (53)* 1.79 (68)* 4.89(186)* 174 9.38 8.41 89.80 36.63
BH
3
0 0 40 0.15 (06) 0.00 (00)
f 0.15 (06) 6 0.31
0.125 0 40 0.75 (30)+ 0.08 (03) 0.83 (33)+ 33 1.69 1.38
0.125 40 40 0.40 (16)* 0.10 (4) 0.50 (20)* 20 1.02 1.02 26.08
MH flies (mwh/flr
3) and BH flies (mwh/TM3) were evaluated.
aStatistical diagnoses according to Frei and Würgler (1995). U-test, two-sided, probability
levels: +, p  0.05 vs. untreated control; *, p  0.05 vs. DXR only.
bConsidering mwh clones from mwh single and twin spots.
cFrequency of clone forma-
tion: clones/flies/48,800 cells (without size correction).
dCalculated as [DXR alone - (DXR + Ti) / DXR alone] X 100, according to Abraham (1994).
eIn-
cluding rare flr
3 single spots.
fOnly mwh single spots can be observed in BH individuals.compared with mutational events in D. melanogaster so-
matic cells.
As can be seen from the data in Table 1 on MH flies
from the ST crossbreed, no differences were observed
among the frequencies of total spots induced by co-treat-
ments with T. impetiginosa 10% or 20% and DXR, when
compared to those from the positive control (DXR alone).
However, T. impetiginosa 40% in association with DXR
displayed a 36.63% inhibition of DXR genotoxicity. Nev-
ertheless, this is not interpreted as an antigenotoxic or pro-
tective effect of T. impetiginosa, since the number of
survivor flies was reduced, thereby indicating T.
impetiginosa toxicity which could be responsible for cell
death or mitotic inhibition. According to Zeiger (2006), if
the test concentrations used are near the stationary or toxic
level on a plate test, a slight increase in toxicity could lead
to lower survival rates, with a parallel decrease in mutant
colonies. Such an apparent antimutagenic effect would
therefore be the result of toxicity rather than anti-
mutagenicity. The same should be true for the results found
in the present study.
Herbal/dietary constituents may be metabolized by
CYPintonontoxicmetabolitesandexcreted,buttheforma-
tion of toxic metabolites is possible. In addition, the inhibi-
tion of CYPs by herbal constituents may decrease the
formation of toxic metabolites and thus inhibit carcino-
genesis, as CYPs play an important role in procarcinogen
activation. The bioactivation of herbal constituents appears
tobeacriticalstepfortoxicityinductioninsomeherbs.The
resultant reactive intermediates bind covalently to DNA
and proteins, leading to organ toxicity and even carcinoge-
nicity. On the other hand, some herbal/dietary constituents
were shown to form reactive intermediates capable of irre-
versibly inhibiting various CYPs (Zhou et al., 2004).
The results shown in Table 2 indicate the significant
potentiating action of T. impetiginosa when administered
simultaneously with DXR, and which was inversely pro-
portional to the concentrations applied, once more indicat-
ing a dose-response correlationship with toxicity. T.
impetiginosa 10% or 20% significantly increased DXR-
induced genotoxicity, which affected all categories of
spots. Nevertheless, in the case of T. impetiginosa 40%,
synergisticactivitywasnotsopronounced,withthesignifi-
cant increase in DXR genotoxicity being limited to the fre-
quency of total spots. The magnitude of comutagenicity
was considerable, leading to enhancements from 23.75 to
94.61%.
Medicinal herbs contain complex mixtures of thou-
sands of components that can exert their action separately
or synergistically (Cai et al., 2004; Romero-Jiménez et al.,
2005). It has been well established that the formation of re-
active drug metabolites is associated with drug toxicity.
Similarly, data are accumulating which suggest the role of
the formation of reactive metabolites/intermediates
through bio-activation in herbal toxicity and carcinogenic-
ity. It has been hypothesized that the resultant reactive me-
tabolites following herbal bio-activation covalently bind to
cellularproteinsandDNA,thusleadingtotoxicityviamul-
tiple mechanisms such as direct cytotoxicity, oncogene ac-
tivation and hypersensitivity reactions (Zhou et al., 2004).
The mechanisms used by T. impetiginosa to interact
with the genotoxicity of DXR were not analyzed directly.
The results observed in the present study allow us to hy-
pothesize that: i) T. impetiginosa constituents may interact
withthoseenzymesystemscatalyzingthemetabolicdetox-
ification of DXR, leading to the enhancement of DXR
mutagenicity; ii) T. impetiginosa constituents generate
superoxideradicalsandstimulatemicrosomaloxidationvia
NAD(P)H. Similar results and conclusions were described
by Lehmann et al. (2000) with tannic acid in association
with mitomycin C, methylmethanesulfonate and nitrogen
mustard in somatic cells of D. melanogaster.
Our findings demonstrated that powdered bark and
stem of T. impetiginosa was toxic, but not genotoxic by it-
self, yet it possesses a considerable potentiating effect on
DXR genotoxity, thereby suggesting that T. impetiginosa
may possess anticarcinogenic potential. Therefore, further
experiments, including carcinogenicity tests, are required
on dose response, appropriate combinations, and potential
toxicity/genotoxicity of T. impetiginosa associations with
chemotherapeutic drugs, to determine the possible risks or
protectionthatcouldbeassociatedwiththeexposureofliv-
ing organisms to this complex mixture.
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